Cohance Lifesciences P/E Ratio
Cohance Lifesciences (COHANCE) P/E ratio is 287.58 (High), EPS (TTM) ₹4.69, current price ₹438.00 on NSE vs historical average P/E of 54.6 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see COHANCE stock price BSE.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
COHANCE P/E Ratio — Valuation Signal & Historical Context
Cohance Lifesciences P/E 287.58 vs historical average 54.6, range 20.06–152.93 — signal: Overvalued.
- Stock appears overvalued with PE of 287.58, suggesting caution for new investments
- Current PE is 426.7% above historical average
- Trading at premium to sector average PE of 55.6
Cohance Lifesciences P/E Ratio Historical Trend
COHANCE annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 287.58 vs historical average 54.6. Also explore Cohance Lifesciences stock price data download to track price trends across different timeframes.
COHANCE Historical P/E Ratio — EPS, Year-End Price & Valuation
Cohance Lifesciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 152.93 | 7.34 | ₹1122.50 | NSE | High |
| 2024 | 61.41 | 11.73 | ₹720.35 | NSE | High |
| 2023 | 33.66 | 14.58 | ₹490.75 | NSE | High |
| 2022 | 33.09 | 14.88 | ₹492.35 | NSE | High |
| 2021 | 26.45 | 17.5 | ₹462.85 | NSE | High |
| 2020 | 20.06 | 16.8 | ₹337.05 | NSE | Moderate |
COHANCE vs Healthcare Peers — P/E Ratio Comparison
Cohance Lifesciences P/E 287.58 vs Healthcare average 55.6, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |